Amphotericin B lipid complex therapy of experimental fungal infections in mice - Wikidata - awgldk - TriplyDB

Amphotericin B lipid complex therapy of experimental fungal infections in mice

Amphotericin B lipid complex therapy of experimental fungal infections in mice

http://www.wikidata.org/entity/Q36753279

about

In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis.Aspergillus fumigatus and aspergillosis Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important?Treatment of murine candidiasis and cryptococcosis with amphotericin B incorporated into egg lecithin-bile salt mixed micelles.Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbits.Efficacy of liposomal amphotericin B with prolonged circulation in blood in treatment of severe pulmonary aspergillosis in leukopenic rats.In vivo activity of amphotericin B lipid complex in immunocompromised mice against fluconazole-resistant or fluconazole-susceptible Candida tropicalis.Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy.The lipid formulations of amphotericin B.Carrier effects on biological activity of amphotericin B.Efficacy of escalating doses of liposomal amphotericin B (AmBisome) against hematogenous Candida lusitaniae and Candida krusei infection in neutropenic mice Antifungal therapy and outcomes in infants with invasive Candida infections.Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products.Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis.An update on the use of antifungal agents.Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis.Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections?AmBisome Induced Avascular Necrosis of the Alae of the Nose of a very young girl suffering from Kala-azar - a Case Report.A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies.Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections.Efficacy of prophylactic aerosol amphotericin B lipid complex in a rat model of pulmonary aspergillosis.Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats.Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation.Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis.Liposomes in the treatment of infections.Liposomes as delivery systems in the prevention and treatment of infectious diseases.Development of liposomal amphotericin B formulation.Amphotericin B lipid complex.

P2860

Q28343158-DBFF0E46-E454-4477-8271-83213C75A7D1 Q28379472-EDF09010-34F1-459F-BC46-9359DCAFA90C Q29617908-65A78BDE-B654-40F5-B607-46ED0AD011C6 Q30424017-ABF80149-FCC7-4FBC-BB78-4BF9E9F2B85C Q30436889-234F4E86-FA26-4964-B9F9-A11E21CF7874 Q31161843-3D51915C-BBE4-46C7-ACA1-AB5365339D09 Q33689767-B486419C-4AD1-4FBA-BCBF-A9EB778F559B Q33692198-1CA2AC9A-CFE4-4308-8E6E-BE27D9F7CD7E Q33749073-CBEDB0F0-E481-4E01-8BA8-D76C05E29B06 Q33749615-5C0150B7-C347-43BC-8164-314BD85F8B87 Q33751032-3F7F4F83-0EA8-4695-A0AB-A89821C4903F Q33978764-4D8FFA5C-AE4C-499E-9C41-A20B26D87A16 Q33978902-CF798E72-467B-4289-9C3D-89BEBAB7FB04 Q33980705-65688EBE-5706-4B1D-AAD5-65305EB68FDE Q34294886-C8217738-60D3-4782-BE2D-2944EDE6241C Q34680675-7FC5C541-67A0-4A65-8A78-7B9428D0822D Q35114249-79B704EF-F21D-4CBD-99C1-47BF741D34CF Q35183734-72BF861A-AB43-4E0C-BC38-9549BD4D180F Q35372581-3BF1512C-F31A-4974-A207-D0321C467134 Q35822610-88BFAC1B-2998-4794-9ED9-F707EA70669A Q35897495-AE14EEC7-51D4-454D-B00F-B1CED1392CD4 Q35904922-09D7CF39-FB70-4158-BA1D-DE8AC8E03748 Q36422661-649A30C9-7AF4-4FCA-BE12-D1AFF42DD2BC Q36489697-AD9A539E-05A2-44C7-A6E6-470EC77D2C43 Q36724783-F62AD38A-BB03-4B7B-A07A-4312094A2475 Q36758184-FAD73FAE-8B82-46EC-B405-F7ECA694E11A Q38077678-17C5B35D-1686-42E7-BD3C-FD2F492D7A2D Q38193337-619AED49-C3F1-4C94-AA1A-AE408346D948 Q38561855-DD3F0075-5936-40BE-9F48-66A89A909D8C Q39221070-0F484CDF-07D2-4EA8-92FD-CDB95F18F522 Q39473015-ADD7064A-D97C-4541-BD17-7C1F48B43B34 Q39537321-3F4CA0B3-8CE4-47EC-A1BB-6FEAE4F4E7D6 Q39783583-D5C752DF-C533-496A-A158-77C9AC55E8F1 Q39784035-A5845F7C-5621-4911-A73D-D04EC1B3432D Q39928680-3F57D830-FC3C-4233-8C3E-B3416E4CAEBA Q40187292-12CB2F25-7FE0-43D1-8C76-63D66347CC51 Q40499095-772E1EC1-8858-4D17-BE2A-56A84D244DCE Q40507955-606135CA-4439-4708-8AEC-AC317A3B8BB4 Q40639958-A15A848B-3739-4465-8C6D-97703E14636A Q40645849-220AFCF5-6D1B-4553-8D23-F08F9B83F296

P2860

Amphotericin B lipid complex therapy of experimental fungal infections in mice

http://www.wikidata.org/entity/Q36753279

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Amphotericin B lipid complex therapy of experimental fungal infections in mice

@en

type

label

Amphotericin B lipid complex therapy of experimental fungal infections in mice

@en

prefLabel

Amphotericin B lipid complex therapy of experimental fungal infections in mice

@en

P1433

Q36753279-F4E95628-1ADE-4CC6-BA46-D41C6491508B

P1476

Q36753279-C7C805FD-531A-44D6-92E9-3C3FCBBD34EA

P2093

Q36753279-14448A46-9E9F-4595-97EC-5EE78E63C3F0

Q36753279-2BA97192-8D1B-4EAB-98D0-EA0623D1859A

Q36753279-2F5792BC-C9E6-43DE-B883-D4FB06748102

Q36753279-4A2E5D5C-0B7D-4A7E-AD7F-100AFE09FA70

Q36753279-568025E3-D847-46D0-AF25-D47C1CE6C9C9

Q36753279-D504CE8E-3C74-4627-B99A-FBBB9185BC3B

Q36753279-D5F2E43B-5D12-4F53-84CF-66D2205B5673

P2860

Q36753279-04F10237-49A3-414C-83A5-8D81B92B7825

Q36753279-0D74A5A0-F3D0-47EF-9174-3661DF8B151A

Q36753279-36986548-FDFC-48F7-8F58-4A095BE9904A

Q36753279-51A5030B-1A4F-4147-B244-0456CCF33C9F

Q36753279-55F70176-F0D1-4183-B7E3-18C0F794C740

Q36753279-576210AB-6EEC-4AF2-9945-5D945DD2AEBD

Q36753279-6259CFA2-27AB-4C76-89BF-FA62C019E942

Q36753279-85105CBB-F710-4034-B864-E8307D6E8CB5

Q36753279-AE0F8094-03E6-4CE6-A35A-EB95553AECDA

Q36753279-AE3748A8-FDDC-4273-8407-3A0DDA2FA88D

P304

Q36753279-31984C97-B34C-4491-9874-F49CF52C5F93

P31

Q36753279-CC94A51C-0901-4631-86BD-864A49583270

P356

Q36753279-5AF6B3D2-CDEB-4FC6-A109-34DE6D1D50E2

P407

Q36753279-9D5A7A5C-AEDF-47BA-9FB4-61451BD1EE93

P433

Q36753279-92E9E27E-2C8F-4ED5-9A30-CCB90592FC97

P478

Q36753279-7F2BFB26-1732-4A84-A7F7-39022B9389CF

P577

Q36753279-FA2FA64F-65D8-4696-9434-23139A566D7A

P5875

Q36753279-D05B4D38-CE2C-4A5C-AB62-911340FBCFD7

P698

Q36753279-1CA65F7A-49BD-40B6-B38D-B1187A92AA70

P932

Q36753279-89BC94E6-7F4C-4AA2-AADD-6C4A6BA612AC

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Amphotericin B lipid complex therapy of experimental fungal infections in mice

@en

P2093

Bonner DP

http://www.w3.org/2001/XMLSchema#string

Clark JM

http://www.w3.org/2001/XMLSchema#string

George RJ

http://www.w3.org/2001/XMLSchema#string

Kunselman L

http://www.w3.org/2001/XMLSchema#string

Olsen SJ

http://www.w3.org/2001/XMLSchema#string

Swerdel MR

http://www.w3.org/2001/XMLSchema#string

Whitney RR

http://www.w3.org/2001/XMLSchema#string

P2860

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice.

Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis.

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

Comparison of fluconazole and amphotericin B in treating histoplasmosis in immunosuppressed mice

Fungal infections in patients with AIDS and AIDS-related complex.

Liposome-encapsulated amphotericin B: a promising new treatment for disseminated fungal infections.

Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice.

Itraconazole, a new triazole that is orally active in aspergillosis.

Treatment of systemic fungal infections with liposomal amphotericin B.

P304

615-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.35.4.615

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

1991-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21087397

http://www.w3.org/2001/XMLSchema#string

P698

2069367

http://www.w3.org/2001/XMLSchema#string

P932

245068

http://www.w3.org/2001/XMLSchema#string